Therapeutics Letter 7 summarized the evidence about optimal drug therapy for primary (idiopathic) hypertension in 1995, concluding that thiazide-like drugs should be first choice.1 With additional evidence, we reiterated that conclusion in 20032 and in...
Fisher, A., Kim, J.D., Carney, G. et al. Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia. BMC Rheumatol 6, 5 (2022)...
Individual participant data meta-analyses (IPDMAs) are challenging to conduct, but they can improve the quality and scope of evidence syntheses. They can be used to standardize participant inclusion criteria and outcome variable definitions, and they...
Josh Levin is a general practitioner working in Victoria. He is a member of the University of British Columbia’s Therapeutics Initiative. As a family doctor who closely follows the emerging trends in the pandemic, I believe...